Award
National Institute of Neurological Disorders and Stroke 5R01NS127403-04
CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease
Recipient
National Institute of Neurological Disorders and Stroke (NINDS)
Award Amount
$589,359.00
Ceiling
$589,359.00
Awarded
July 25, 2025
Identifier
5R01NS127403-04
Research project funded by NINDS to develop treatments for Krabbe disease using CGT and ACD inhibitors, gene therapy, and stem cell transplantation.
Description
The project involves research on Krabbe disease using CGT and ACD inhibitors, gene therapy, and stem cell transplantation. The goal is to develop strategies to improve long-term protection for patients.